Before Invest
PFIZER INC logo

PFIZER INC

PFE
Pharmaceutical Preparations
Last filing · Quarter 2 · Jun 28, 2026
Financial Statements Ratios
Export XLSX
Statement
Income StatementBalance Sheet
Period
Annual Quarterly
Order
Unlock 14 years
Format
% Change
Rows
USD ($)
$ in Millions 		Dec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016Dec 31, 2015Dec 31, 2014Dec 31, 2013Dec 31, 2012Dec 31, 2011Dec 31, 2010Dec 31, 2009
Assets
                 
Cash and cash equivalents
$ 1,142
$ 1,043
$ 2,853
Short-term investments
12,454
19,434
9,837
Trade accounts receivable, net of allowance for doubtful accounts: 2025—$427; 2024—$438
11,874
11,463
11,177
Short-term loans
-
-
-
Inventories
10,654
10,851
10,189
Current tax assets
3,967
3,314
3,978
Other current assets
2,808
4,253
5,299
Current assets of discontinued operations and other assets held for sale
-
-
-
Taxes and other current assets
-
-
-
Assets of discontinued operations and other assets held for sale
-
-
-
Total current assets
42,898
50,358
43,333
Equity-method investments
-
217
11,637
Long-term investments
1,621
2,010
3,731
Long-term investments and loans
-
-
-
Property, plant and equipment, net
19,317
18,393
18,940
Identifiable intangible assets, net
53,731
55,411
64,900
Goodwill
71,264
68,527
67,783
Noncurrent deferred tax assets and other noncurrent tax assets
9,699
8,662
3,706
Other noncurrent assets
9,631
9,817
12,471
Noncurrent assets of discontinued operations
-
-
-
Taxes and other noncurrent assets
-
-
-
Total assets
208,160
213,396
226,501
Liabilities and Equity
                 
Short-term borrowings, including current portion of long-term debt: 2025—$2,997; 2024—$3,747
3,154
6,946
10,350
Trade accounts payable
5,240
5,633
6,710
Dividends payable
2,445
2,437
2,372
Income taxes payable
3,103
2,910
2,349
Accrued compensation and related items
3,610
3,838
2,776
Deferred revenues
784
1,511
2,700
Other current liabilities
18,648
19,720
20,537
Current liabilities of discontinued operations
-
-
-
Liabilities held for sale
-
-
-
Total current liabilities
36,984
42,995
47,794
Long-term debt
61,641
57,405
61,538
Pension and postretirement benefit obligations
2,041
2,115
2,167
Pension benefit obligations
-
-
-
Postretirement benefit obligations
-
-
-
Noncurrent deferred tax liabilities
2,401
2,122
640
Other taxes payable
3,591
6,112
8,534
Other noncurrent liabilities
14,725
14,150
16,539
Total liabilities
121,385
124,899
137,213
Preferred stock, no par value, at stated value; 27 shares authorized; no shares issued or outstanding as of December 31, 2023 and December 31, 2022
-
-
0
Common stock, $0.05 par value; 12,000 shares authorized; issued: 2025—9,621; 2024—9,593
481
480
478
Additional paid-in capital
94,469
93,603
92,631
Treasury stock, shares at cost: 2025—3,935; 2024—3,926
115,015
114,763
114,487
Employee benefit trusts
-
-
-
Retained earnings
114,610
116,725
118,353
Accumulated other comprehensive loss
(8,069)
(7,842)
(7,961)
Total Pfizer Inc. shareholders’ equity
86,476
88,203
89,014
Equity attributable to noncontrolling interests
299
294
274
Total equity
86,775
88,497
89,288
Total liabilities and equity
208,160
213,396
226,501
Allowance for Doubtful Accounts Receivable, Current
-
-
-
Long-term Debt, Current Maturities
-
-
-
Preferred Stock, Shares Authorized
-
-
-
Preferred Stock, Shares Issued
-
-
-
Common Stock, Par or Stated Value Per Share
-
-
-
Common Stock, Shares Authorized
-
-
-
Common Stock, Shares, Issued
-
-
-
Treasury Stock, Shares
-
-
-